|View printer-friendly version|
|April 13, 2005 11:08 a.m.|
|Teva Announces Approval Of Metformin Hcl Extended Release Tablets, 750 Mg|
Jerusalem, Israel, April 13, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Metformin Hydrochloride Extended Release Tablets, 750 mg. Shipment of this product is expected to begin immediately.